From somatic mutations to Quotient

2023-12-04T15:48:22+00:0021 November 2023|

We spoke to Dr IƱigo Martincorena, group leader at the Wellcome Sanger Institute and academic co-founder of Quotient Therapeutics. Quotient is a new company leveraging Sanger Institute research to innovate the way drugs are discovered.